Record

RefNoJV/6/9
LevelSeries
TitleCorrespondence between Dr Alfred Fishman and Sir John Vane
Date14 December 1984 - 2 December 1985
DescriptionDr Fishman was Director of the Cardiovascular Pulmonary Division at the Hospital of the University of Pennsylvania. His work involved research into prostaglandins, and he was also an advocate of animal experimentation. The correspondence in this file refers to a paper about animal experimentation and possible alternatives by Stevens, which appeared in 'Nature' and which both men consider to be 'dangerous' (December 1984); Dr Fishman's research into the endothelial surface (December 1984); the possibility of holding a joint meeting on animal experimentation in either London or Cambridge (February 1985); Sir John Vane's offer of possible access to 'a trial of continuous infusion of prostacyclin in a patient with primary pulmonary hypertension' (March 1985); and Dr Fishman's request that Sir John Vane write a piece for the new journal of the International Union of Physiological Sciences, November 1985.
Extent4 items
FormatTypescript
AccessStatusOpen
AccessConditionsClosed until 02/12/2015, opened 29/02/2016
Add to My Items

    Collection highlights

    Browse the records of some of our collections, which cover all branches of science and date from the 12th century onwards. These include the published works of Fellows of the Royal Society, personal papers of eminent scientists, letters and manuscripts sent to the Society or presented at meetings, and administrative records documenting the Society's activities since our foundation in 1660.

    The Royal Society

    The Royal Society is a Fellowship of many of
    the world's most eminent scientists and is the
    oldest scientific academy in continuous existence.
    Registered charity number 207043

    Website design ©CalmView



    CONTACT US

    + 44 207 451 2500
    (Lines open Mon-Fri, 9:00-17:00. Excludes bank holidays)

    6-9 Carlton House Terrace, London SW1Y 5AG

    Email Us →

    SUBSCRIBE

    Subscribe to our newsletters to be updated with the
    latest news on innovation, events, articles and reports.

    Subscribe →

    © CalmView